Landscape Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,083
Closed -$359K 1084
2022
Q1
$359K Sell
1,083
-3,431
-76% -$1.06M 0.05% 354
2021
Q4
$1.62M Sell
4,514
-4,547
-50% -$1.54M 0.23% 94
2021
Q3
$2.95M Buy
+9,061
New +$3.07M 0.41% 59
2021
Q2
Sell
-3,294
Closed -$1.05M 704
2021
Q1
$1.05M Buy
+3,294
New +$1.05M 0.16% 115
2020
Q2
Sell
-2,025
Closed -$294K 648
2020
Q1
$294K Sell
2,025
-6,405
-76% -$1.06M 0.03% 406
2019
Q4
$1.44M Sell
8,430
-2,761
-25% -$512K 0.1% 245
2019
Q3
$1.99M Buy
+11,191
New +$2.42M 0.15% 167
2017
Q1
Sell
-2,480
Closed -$279K 651
2016
Q4
$279K Buy
+2,480
New +$287K 0.04% 432

Other funds holding ABMD

Landscape Capital Management's ABMD Position: Q2 2022 in Review

Landscape Capital Management sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,083 shares — an estimated $359K sold.

Landscape Capital Management first reported a position in ABMD in Q4 2016 and held it in 8 quarters. The position peaked at $2.95M in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Landscape Capital Management reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Landscape Capital Management sold 1,083 Abiomed Inc shares in Q2 2022, an estimated $359K.
  • Landscape Capital Management first reported a position in Abiomed Inc in Q4 2016 and held it in 8 quarters.
  • Landscape Capital Management's Abiomed Inc position peaked at $2.95M in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Landscape Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.